Vedolizumab for induction and maintenance of remission in ulcerative colitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Vedolizumab for induction and maintenance of remission in ulcerative colitis

Published:2014-08-08 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Bickston Stephen J¹,Behm Brian W²,Tsoulis David J³,Cheng Jianfeng⁴,MacDonald John K³,Khanna Reena³,Feagan Brian G³

Affiliation:

1. Center for Inflammatory Bowel Diseases; Virginia Commonwealth University Health System Box 980341 Richmond VA USA 23298

2. University of Virginia Health Systems; UVA Digestive Health Center of Excellence; Box 800708 Charlottesville VA USA 22908

3. Robarts Research Institute; Robarts Clinical Trials; P.O. Box 5015 100 Perth Drive London ON Canada N6A 5K8

4. University of North Carolina Charlotte Campus; Carolinas Medical Center; 1025 Morehead Medical Drive Charlotte NC USA 28204

Publisher

Wiley

Subject

Pharmacology (medical)

Reference50 articles.

1. An ascending dose trial of a humanised a4b7 antibody in ulcerative colitis;Feagan;Gastroenterology,2000

2. Efficacy and safety of a humanized A4B7 antibody in active Crohn's disease (CD);Feagan;Gastroenterology,2003

3. Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin;Feagan;New England Journal of Medicine,2005

4. Improvements in health-related quality of life in patients with ulcerative colitis treated with vedolizumab;Feagan;Journal of Crohn's and Colitis,2014

5. Vedolizumab maintenance therapy for ulcerative colitis: Results of gemini I, a randomized, placebo-controlled, double-blind, multicenter phase 3 trial;Feagan;American Journal of Gastroenterology,2012

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-ulcerative colitis effect of rotating magnetic field on DSS-induced mice by modulating colonic inflammatory deterioration;Molecular Immunology;2024-08

2. The continuing value of mesalazine as first-line therapy for patients with moderately active ulcerative colitis;Frontiers in Gastroenterology;2024-06-03

3. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2);Zeitschrift für Gastroenterologie;2024-05

4. Biologics, Small Molecules and More in Inflammatory Bowel Disease: The Present and the Future;Future Pharmacology;2024-03-14

5. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.1) – Februar 2023 – AWMF-Registriernummer: 021-009;Zeitschrift für Gastroenterologie;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3